Latest Breaking News On - Targeted oncology - Page 1 : comparemela.com

Treatment-Free Survival Extended With Nivolumab/Cabozantinib in Advanced Renal Cell Carcinoma

Nivolumab/cabozantinib combination therapy showed consistent benefits across various subgroups in patients with advanced renal cell carcinoma (RCC).

Sanjay Juneja: 'When There Is a Need and You Can, You Should'

In the interview with Targeted Oncology, Sanjay K. Juneja, MD, 2024 Oncology Icons honoree, discusses the transformative power of collaboration, technology, and compassionate care in shaping his career, as well as the future of cancer treatment.

Targeted Oncology™ announces first recipient of 2024 for its Oncology Icons award program

This award highlights the exceptional work of oncology clinicians practicing in a community setting Targeted Oncology is pleased to announce this year’s first recipient of the Oncology Icons award, Sanjay K. Juneja, M.D. This award highlights the exceptional work of oncology clinicians practicing in a community setting. CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments

Targeted Oncology™ announces first recipient of 2024 for

This award highlights the exceptional work of oncology clinicians practicing in a community setting.

Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum